Editorial
 REVISED NORMS FOR ISSUE OF PATENTS   
 Wednesday, August 27, 2014 
 The Section 3(d) of the amended Indian Patent Act of 2005 is a key safeguard against ever greening of a drug patent by the inventor companies by making some incremental changes to the original molecule. 
  Past Editorial...  
TODAY'S NEWS
12:00  [IST]Boston Scientific's NECTAR-HF trial fails to meet pre-specified 6-month primary efficacy endpoint
11:00  [IST]Novo Nordisk launches Ryzodeg in Mexico for people with type 2 diabetes
10:00  [IST]US FDA approves UCB’s Vimpat as monotherapy in treatment of patients with partial-onset seizures
09:00  [IST]Daiichi Sankyo announces details of TaNeDS collaborative drug discovery programme in Europe
more news >>
TOP NEWS
08:00  [IST]Health ministry considering clinical trial waiver for cancer drugs Aflibercept & Trastuzumab emtansine
08:00  [IST]Maha FDA plans massive crackdown on illegal cord blood banks in state
08:00  [IST]Schneider eyes greenfield hospital projects to install uninterruptable power solution to save 30% costs
08:00  [IST]Hyderabad scientist develops new stem cell technique to repair damaged eye
08:00  [IST]'Govt should frame clear rules to fix separate MRP for generic drugs'
08:00  [IST]Health ministry to set up expert panel to re-examine issue of allowing trial in hospitals with less than 50 beds
more news >>
YESTERDAY'S NEWS
18:00  [IST]Novartis' heart failure medicine LCZ696 cut cardiovascular deaths by 20% vs ACE-inhibitor in PARADIGM-HF trial
17:30  [IST]Cipla launches Serroflo in Germany and Sweden with affordable high quality alternatives
17:00  [IST]KPMG-FICCI report says cost effective quality healthcare to boost Indian medical tourism
16:40  [IST]AIMS conducts first pancreas kidney transplant in Kerala
16:00  [IST]Wockhardt's two anti infective drugs get QIDP status from US FDA
15:00  [IST]DICOM Grid introduces interactive guide to display image-enabling electronic medical record
more news >>
INTERVIEW  
KSPC works out strategies with Kerala govt to enforce Section 42 of Pharmacy Act in State
B Rajan, president of KSPC
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Is the union health ministry's recent move to increase the number of drugs covered under the national list of essential medicines (NLEM) justified?
 
 
 
 

   
 
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
US FDA: REFUSAL
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
 
 
 
 
Copyright © 2010 Saffron Media Pvt. Ltd |